Image

Digitalized Clinical Decision Support for the Prevention of Postoperative Delirium (POD)

Recruiting
70 years of age
Both
Phase N/A

Powered by AI

Overview

The project aims to improve patient safety, reduce barriers to the implementation of current guideline recommendations, reduce workload in clinics, increase efficiency in work processes and close gaps in care.

Description

Postoperative delirium (POD) is the most common post-operative complication in the 70+ age group, affecting approximately fifteen percent of elderly patients. POD is characterized by impaired attention, awareness, and cognitive function. Both patients and their families are severely affected by the effects of this condition. While symptoms of POD occur during hospitalization, they have a critical impact on post-hospitalization quality of life, dependency on long-term care, and life expectancy.

The overarching goal of the Digi-POD project consortium is to develop a digital decision support system that makes current evidence-based guideline recommendations for POD machine-readable and allows automated, real-time validation against clinical data.

Eligibility

Study patients:

Inclusion Criteria:

  • Age ≥ 70 years
  • Male and female patients
  • Patients who are insured through statutory health insurance
  • Patients capable of giving consent for inclusion: by the patient, preoperatively
  • Patients under guardianship for inclusion: written declaration of consent by guardian
  • Operation (elective)

Exclusion Criteria:

  • Insufficient language skills
  • Moribund patients

Study relatives

Inclusion Criteria:

  • Age ≥ 18 years
  • Male and female relatives
  • Relatives capable of giving consent for inclusion

Exclusion Criteria:

  • Insufficient language skills
  • No consent for data entry

Substudy of the Charité - University Berlin:

Inclusion criteria:

  • All inpatients ≥ 18 years of age who have undergone delirium screening with a validated delirium screening instrument

Study details

Postoperative Delirium

NCT06445153

Charite University, Berlin, Germany

15 June 2024

Step 1 Get in touch with the nearest study center
What happens next?
  • You can expect the study team to contact you via email or phone in the next few days.
  • Sign up as volunteer  to help accelerate the development of new treatments and to get notified about similar trials.

You are contacting

Investigator Avatar

Primary Contact

site

FAQs

Learn more about clinical trials

What is a clinical trial?

A clinical trial is a study designed to test specific interventions or treatments' effectiveness and safety, paving the way for new, innovative healthcare solutions.

Why should I take part in a clinical trial?

Participating in a clinical trial provides early access to potentially effective treatments and directly contributes to the healthcare advancements that benefit us all.

How long does a clinical trial take place?

The duration of clinical trials varies. Some trials last weeks, some years, depending on the phase and intention of the trial.

Do I get compensated for taking part in clinical trials?

Compensation varies per trial. Some offer payment or reimbursement for time and travel, while others may not.

How safe are clinical trials?

Clinical trials follow strict ethical guidelines and protocols to safeguard participants' health. They are closely monitored and safety reviewed regularly.
Add a private note
  • abc Select a piece of text.
  • Add notes visible only to you.
  • Send it to people through a passcode protected link.